|
Q3 FY2017
As of Jan 31, 2017
|
Q2 FY2017
As of Oct 31, 2016
|
Q1 FY2017
As of Jul 31, 2016
|
Q4 FY2016
As of Apr 30, 2016
|
Q3 FY2016
As of Jan 31, 2016
|
Q2 FY2016
As of Oct 31, 2015
|
Q1 FY2016
As of Jul 31, 2015
|
Q4 FY2015
As of Apr 30, 2015
|
Q3 FY2015
As of Jan 31, 2015
|
Q2 FY2015
As of Oct 31, 2014
|
Q1 FY2015
As of Jul 31, 2014
|
Q4 FY2014
As of Apr 30, 2014
|
Q3 FY2014
As of Jan 31, 2014
|
Q2 FY2014
As of Oct 31, 2013
|
Q1 FY2014
As of Jul 31, 2013
|
Q4 FY2013
As of Apr 30, 2013
|
Q3 FY2013
As of Jan 31, 2013
|
Q2 FY2013
As of Oct 31, 2012
|
Q1 FY2013
As of Jul 31, 2012
|
Q4 FY2012
As of Apr 30, 2012
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Due from related party | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Investment in joint venture company, at cost | ||||||||||||||||||||
| Goodwill, net | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES & SHAREHOLDERS' DEFICIT | ||||||||||||||||||||
| Accounts payable and accruals | ||||||||||||||||||||
| Loans from related parties | ||||||||||||||||||||
| Loans payable | ||||||||||||||||||||
| Convertible notes payable, net | ||||||||||||||||||||
| Derivative liabilities | ||||||||||||||||||||
| Due to related parties | ||||||||||||||||||||
| Loan payable | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Loans payable | ||||||||||||||||||||
| Due to related parties | ||||||||||||||||||||
| Liabilities held for sale | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| Common stock, 75,000,000 shares authorized, $0.001 par value; 52,336,449 and 34,791,666 shares issued and outstanding as of April 30, 2016 and 2015, respectively | ||||||||||||||||||||
| Common stock, 75,000,000 shares authorized, $0.001 par value; 63,928,163 and 52,336,499 shares issued and outstanding as of January 31, 2017 and April 30, 2016, respectively | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Shares to be issued | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| TOTAL STOCKHOLDERS' DEFICIT | ||||||||||||||||||||
| TOTAL LIABILITIES & STOCKHOLDERS' DEFICIT | ||||||||||||||||||||
Loading...
